TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tivic Health Systems ( (TIVC) ) just unveiled an announcement.
On November 12, 2025, Tivic Health Systems‘ board decided to wind down its ClearUP business by the end of the year to focus on its biopharma program, incurring costs of approximately $347,000 in the third quarter and expecting additional expenditures of $20,000 to $50,000. The company anticipates minimal revenue until regulatory approval and commercialization of its other products. Tivic reported a net loss of $2.6 million for the third quarter of 2025, compared to $1.4 million in 2024, as it transitions to focus on its biologics pipeline, including the development of Entolimod for military and medical applications.
Spark’s Take on TIVC Stock
According to Spark, TipRanks’ AI Analyst, TIVC is a Neutral.
The overall stock score of 43 reflects Tivic Health Systems’ current financial difficulties, including declining revenues and negative profitability. However, recent strategic initiatives and corporate events provide some optimism for future growth. The stock’s technical indicators and valuation remain weak, necessitating significant improvements in financial performance and market sentiment to enhance stock attractiveness.
To see Spark’s full report on TIVC stock, click here.
More about Tivic Health Systems
Tivic Health Systems, Inc. is a diversified immunotherapeutics company that utilizes biopharmaceutical and bioelectronic systems to address unmet medical needs by targeting the immune system. The company is focused on developing biologics compounds that activate immune pathways to prevent cell death in bone marrow and epithelial tissues, with its lead drug candidate, Entolimod, aimed at treating acute radiation syndrome.
Average Trading Volume: 961,709
Technical Sentiment Signal: Sell
Current Market Cap: $3.8M
For a thorough assessment of TIVC stock, go to TipRanks’ Stock Analysis page.